Parallax Volatility Advisers, L.P. Charles River Laboratories International, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $447,744 - $601,546	-2,200 Reduced 62.86%	1,300 $352,000
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $131,616 - $191,072	-800 Reduced 18.6%	3,500 $827,000
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $836,092 - $935,723	4,300 New	4,300 $842,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $182,440 - $250,540	1,000 New	1,000 $196,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $183,717 - $272,160	-900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $178,857 - $253,477	700 Added 350.0%	900 $256,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $26 Million - $32 Million	-69,800 Reduced 99.71%	200 $83,000
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $9.77 Million - $11.1 Million	-44,000 Reduced 38.6%	70,000 $17.5 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $20 Million - $25.8 Million	114,000 New	114,000 $25.8 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $4.94 Million - $5.94 Million	-40,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $4.19 Million - $5.87 Million	40,000 New	40,000 $5.81 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.